Status:
COMPLETED
Aquacel Hypersensitivity Dressing in TJAs
Lead Sponsor:
Rush University Medical Center
Conditions:
Contact Allergic Dermatitis
Adverse Skin Reaction
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The aim of this multi-surgeon, single institution study is to prospectively evaluate the incidence of allergic contact dermatitis (ACD) following application of AQUACEL Ag, a silver-containing hydrofi...
Detailed Description
Level I: Prospective Cohort Study Patients will be recruited into the study after completing a standard questionnaire for pre-operative enrollment. After meeting inclusion criteria and passing the scr...
Eligibility Criteria
Inclusion
- Patients older than 18 years that underwent primary total hip arthroplasty (THA)
- Patients older than 18 years that underwent primary total or unicompartmental knee arthroplasty (TKA/UKA)
Exclusion
- Revision surgery
- Prior history of allergic contact dermatitis
- Prior history of non-TJA or UKA surgery with AQUACEL Ag dressing post-op
- Occupational exposure to surgical dressings
- Documented history of silver allergy
Key Trial Info
Start Date :
August 18 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 3 2025
Estimated Enrollment :
396 Patients enrolled
Trial Details
Trial ID
NCT06011629
Start Date
August 18 2023
End Date
June 3 2025
Last Update
June 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rush University Medical Center
Chicago, Illinois, United States, 60612